Ibrutinib or Chemo-Immunotherapy As Second Line Treatment in Waldenstrom Macroglobulinaemia? a Real-Life Multicentre StudyFrancesco Autore, Luca Laurenti, Diana Giannarelli et al.|Blood|2024Cited by 0
Ibrutinib or non-BTK inhibitor therapy in relapsed Waldenström macroglobulinemia: a real-life multicenter Italian studyF. Autore, Luca Laurenti, Alessandra Tedeschi et al.|Blood Advances|2026Cited by 0